FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

88736007: Betamethasone dipropionate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
147123015 Betamethasone dipropionate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
831482017 Betamethasone dipropionate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
8491000188114 bétaméthasone dipropionate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
794631000172118 dipropionate de bétaméthasone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betamethasone dipropionate Is a Product containing betamethasone (medicinal product) false Inferred relationship Some
Betamethasone dipropionate Is a Betamethasone false Inferred relationship Some
Betamethasone dipropionate Is a Synthetic glucocorticoid, fluorinated false Inferred relationship Some
Betamethasone dipropionate Is a Pregnane (substance) false Inferred relationship Some
Betamethasone dipropionate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Betamethasone true Inferred relationship Some
Betamethasone dipropionate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that modifies the immune response or the functioning of the immune system. true Inferred relationship Some
Betamethasone dipropionate Is a Immunomodulator false Inferred relationship Some
Betamethasone dipropionate Is a Fluorinated corticosteroid false Inferred relationship Some
Betamethasone dipropionate Is a Glucocorticoid (substance) false Inferred relationship Some
Betamethasone dipropionate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin true Inferred relationship Some
Betamethasone dipropionate Is a Betamethasone ester true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Betamethasone dipropionate 0.5mg/g cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone dipropionate Inferred relationship Some
Betamethasone dipropionate 0.5mg/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone dipropionate Inferred relationship Some
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone dipropionate Inferred relationship Some
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone dipropionate Inferred relationship Some
Betamethasone dipropionate 0.5mg cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone dipropionate Inferred relationship Some
Betamethasone dipropionate 0.5% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone dipropionate Inferred relationship Some
Betamethasone dipropionate 0.05% lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone dipropionate Inferred relationship Some
Betamethasone dipropionate 0.05% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone dipropionate Inferred relationship Some
Betamethasone dipropionate + clotrimazole 0.64mg/10mg cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone dipropionate Inferred relationship Some
Betamethasone dipropionate + clotrimazole 0.5mg/10mg lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone dipropionate Inferred relationship Some
Betamethasone dipropionate + clotrimazole The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone dipropionate Inferred relationship Some
Calcipotriene 0.005%/betamethasone 0.064% topical suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Betamethasone dipropionate Inferred relationship Some
Augmented betamethasone dipropionate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. False Betamethasone dipropionate Inferred relationship Some
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Betamethasone dipropionate Inferred relationship Some 1
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Betamethasone dipropionate Inferred relationship Some 1
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Betamethasone dipropionate Inferred relationship Some 1
Product containing precisely betamethasone dipropionate 640 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Betamethasone dipropionate Inferred relationship Some 1
Product containing precisely betamethasone dipropionate 640 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Betamethasone dipropionate Inferred relationship Some 1
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Betamethasone dipropionate Inferred relationship Some 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Betamethasone dipropionate Inferred relationship Some 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Betamethasone dipropionate Inferred relationship Some 1
Betamethasone (as betamethasone dipropionate) 5 mg/g cutaneous ointment The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Betamethasone dipropionate Inferred relationship Some 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Betamethasone dipropionate Inferred relationship Some 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Betamethasone dipropionate Inferred relationship Some 1
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Betamethasone dipropionate Inferred relationship Some 1
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Betamethasone dipropionate Inferred relationship Some 1
Betamethasone (as betamethasone dipropionate) 500 microgram/mL and salicylic acid 30 mg/mL cutaneous lotion The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Betamethasone dipropionate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start